Provided by Tiger Trade Technology Pte. Ltd.

Omnicell

32.61
-0.7900-2.37%
Volume:179.20K
Turnover:5.91M
Market Cap:1.48B
PE:722.06
High:33.61
Open:33.43
Low:32.55
Close:33.40
52wk High:55.00
52wk Low:22.66
Shares:45.44M
Float Shares:44.35M
Volume Ratio:0.60
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0452
EPS(LYR):0.0400
ROE:0.17%
ROA:0.36%
PB:1.20
PE(LYR):815.25

Loading ...

Omnicell EVP and Chief Legal/Admin Officer Corey J. Manley Reports Disposal of Common Shares

Reuters
·
Dec 18, 2025

Taking Stock of Omnicell (OMCL) After Titan XT Launch: What the New Platform Means for Valuation

Simply Wall St.
·
Dec 15, 2025

Omnicell Is Maintained at Buy by Benchmark

Dow Jones
·
Dec 09, 2025

Omnicell Chairman, President and CEO Randall A. Lipps Reports Disposal of Common Shares

Reuters
·
Dec 04, 2025

Omnicell Hosts Innovation Update and Q&A Session at ASHP Midyear Clinical Meeting

Reuters
·
Dec 02, 2025

Omnicell (OMCL): Rethinking Valuation After a Recent Rebound in Share Price

Simply Wall St.
·
Nov 25, 2025

Omnicell (OMCL): Evaluating Valuation After Q3 Earnings Beat, Raised Guidance, and Buyback Progress

Simply Wall St.
·
Nov 09, 2025

Omnicell’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
Nov 01, 2025

Omnicell Is Maintained at Buy by Benchmark

Dow Jones
·
Oct 31, 2025

Benchmark Co. Remains a Buy on Omnicell (OMCL)

TIPRANKS
·
Oct 31, 2025

Why Omnicell (OMCL) Stock Is Trading Up Today

stock_story_highlight
·
Oct 31, 2025

Omnicell Up Nearly 12%, on Pace for Largest Percent Increase Since October 2024 -- Data Talk

Dow Jones
·
Oct 31, 2025

Craig-Hallum Sticks to Their Buy Rating for Omnicell (OMCL)

TIPRANKS
·
Oct 30, 2025

Stock Track | Omnicell Soars 8.22% Pre-market on Strong Q3 Results and Raised Guidance

Stock Track
·
Oct 30, 2025

Omnicell Unveils Strategy to Drive Autonomous Pharmacy Transformation and Expand Recurring Revenue

Reuters
·
Oct 30, 2025

Omnicell Q3 adjusted EPS beats estimates, driven by connected devices and services

Reuters
·
Oct 30, 2025

Omnicell Reports Q3 Revenue and Earnings Above Guidance

Reuters
·
Oct 30, 2025

BRIEF-Omnicell Q3 Revenue USD 311 Million

Reuters
·
Oct 30, 2025

Omnicell Q3 Adj. EPS $0.51 Beats $0.36 Estimate, Sales $310.631M Beat $295.587M Estimate

Benzinga
·
Oct 30, 2025

Omnicell Outlook FY Adj EPS $1.63 - $1.73

THOMSON REUTERS
·
Oct 30, 2025